AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10633526 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 8
Study 7501382 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley's canalith repositioning procedure
Number of subjects: 36
Study 7501382 — intervention group
Group type: COMPARATOR
Intervention: Placebo maneuver
Number of subjects: 36
Study 1958007 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BU), 1200 micrograms daily, intranasally for 14 days
Number of subjects: 0
Study 1958007 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BE), 400 micrograms daily, intranasally for 14 days
Number of subjects: 0
Study 1958007 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 0
Study 7044607 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (coronary bypass surgery)
Number of subjects: 768
Study 7044607 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 768
Study 30916463 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP; n = 179)
Number of subjects: 303
Study 30916463 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (MET; n = 124)
Number of subjects: 303
Study 30916463 — intervention group
Group type: COMPARATOR
Intervention: Methadone treatment (for methadone-randomized individuals)
Number of subjects: 303
Study 30916463 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine treatment (for buprenorphine-randomized individuals)
Number of subjects: 303
Study 30916463 — intervention group
Group type: COMPARATOR
Intervention: Switching to buprenorphine (for methadone-randomized individuals)
Number of subjects: 303
Study 30916463 — intervention group
Group type: COMPARATOR
Intervention: Switching to methadone (for buprenorphine-randomized individuals)
Number of subjects: 303
Study 29135073 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily
Number of subjects: 40
Study 29135073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29135073 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 27004388 — intervention group
Group type: EXPERIMENTAL
Intervention: McGRATH MAC video laryngoscope
Number of subjects: 80
Study 27004388 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 80
Study 23825004 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable resistance training
Number of subjects: 37
Study 23825004 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant resistance training
Number of subjects: 37
Study 23825004 — intervention group
Group type: COMPARATOR
Intervention: Non-training control group
Number of subjects: 37
Study 22264303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (10 grams with normal saline)
Number of subjects: 141
Study 22264303 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline only)
Number of subjects: 141
Study 19172129 — intervention group
Group type: EXPERIMENTAL
Intervention: Galacto-oligosaccharides (GOS) 5 g/L
Number of subjects: 159
Study 19172129 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-on formula (control)
Number of subjects: 159
Study 17224283 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD EXPRESS Compression System
Number of subjects: 18
Study 17224283 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-layer bandage
Number of subjects: 18
Study 17224283 — intervention group
Group type: COMPARATOR
Intervention: No bandage
Number of subjects: 18
Study 15975373 — intervention group
Group type: EXPERIMENTAL
Intervention: CorX system (group A)
Number of subjects: 204
Study 15975373 — intervention group
Group type: COMPARATOR
Intervention: Standard CPB (group B)
Number of subjects: 204
Study 11944885 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepiapterin and 6-biopterin photo-oxidation by UVA/UVB irradiation
Number of subjects: 0
Study 11944885 — intervention group
Group type: COMPARATOR
Intervention: UVA/UVB irradiation
Number of subjects: 0
Study 11487138 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical trephination
Number of subjects: 50
Study 11487138 — intervention group
Group type: COMPARATOR
Intervention: Mock trephination
Number of subjects: 50
Study 9771245 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose of inhaled steroids
Number of subjects: 28
Study 9771245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 7829006 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc acetate (15 mg/kg per day) for a month
Number of subjects: 32
Study 7829006 — intervention group
Group type: COMPARATOR
Intervention: Control group (without zinc)
Number of subjects: 32
Study 3407604 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (GI) foods
Number of subjects: 8
Study 3407604 — intervention group
Group type: COMPARATOR
Intervention: High glycemic index (GI) foods
Number of subjects: 8
Study 3407604 — intervention group
Group type: EXPERIMENTAL
Intervention: High GI and Low GI foods
Number of subjects: 8
Study 7525446 — intervention group
Group type: EXPERIMENTAL
Intervention: GCSF primed peripheral blood progenitor cell collections
Number of subjects: 62
Study 7525446 — intervention group
Group type: COMPARATOR
Intervention: Post chemotherapy GCSF
Number of subjects: 62
Study 748987 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal 15-methyl-PGF2alpha methyl ester (3.0 mg)
Number of subjects: 100
Study 748987 — intervention group
Group type: COMPARATOR
Intervention: Intra-amniotic PGF2alpha (50 mg)
Number of subjects: 100
Study 31003804 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-Free Moms intervention (financial incentives)
Number of subjects: 175
Study 31003804 — intervention group
Group type: COMPARATOR
Intervention: Usual smoking counseling (Control)
Number of subjects: 175
Study 29861487 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D fortified foods (12 weeks trial)
Number of subjects: 534
Study 26825916 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitative Kinesio Taping (KT)
Number of subjects: 28
Study 26825916 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory Kinesio Taping (KT)
Number of subjects: 28
Study 26825916 — intervention group
Group type: COMPARATOR
Intervention: Hypafix taping
Number of subjects: 28
Study 24801369 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 70
Study 24801369 — intervention group
Group type: COMPARATOR
Intervention: Casein protein
Number of subjects: 70
Study 24801369 — intervention group
Group type: COMPARATOR
Intervention: Glucose control
Number of subjects: 70
Study 22507444 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive focal muscle vibration (rMV)
Number of subjects: 49
Study 22507444 — intervention group
Group type: COMPARATOR
Intervention: Placebo vibratory treatment (Control Group)
Number of subjects: 49
Study 21054290 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior change intervention (BCI)
Number of subjects: 204
Study 21054290 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI plus pedometer (pedometer plus)
Number of subjects: 204
Study 21054290 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 204
Study 21054290 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes (not specified)
Number of subjects: 204
Study 17652313 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler echocardiography
Number of subjects: 163
Study 17652313 — intervention group
Group type: COMPARATOR
Intervention: Invasive measurement (right heart catheterisation)
Number of subjects: 163
Study 15782425 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% CO2 inhalation for 20 min
Number of subjects: 20
Study 15782425 — intervention group
Group type: COMPARATOR
Intervention: Air inhalation for 20 min
Number of subjects: 20
Study 12404882 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (20 mg)
Number of subjects: 11
Study 12404882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 10101361 — intervention group
Group type: EXPERIMENTAL
Intervention: CT fluoroscopy
Number of subjects: 20
Study 10101361 — intervention group
Group type: COMPARATOR
Intervention: Conventional CT guidance
Number of subjects: 20
Study 7582380 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (751 mg/l naringin)
Number of subjects: 12
Study 7582380 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 2348453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 108
Study 2348453 — intervention group
Group type: EXPERIMENTAL
Intervention: Video game
Number of subjects: 108
Study 6997537 — intervention group
Group type: EXPERIMENTAL
Intervention: KW-1062 at 240 mg/day
Number of subjects: 155
Study 6997537 — intervention group
Group type: EXPERIMENTAL
Intervention: KW-1062 at 360 mg/day
Number of subjects: 155
Study 6997537 — intervention group
Group type: EXPERIMENTAL
Intervention: KW-1062 for acute and uncomplicated pyelonephritis
Number of subjects: 155
Study 6997537 — intervention group
Group type: EXPERIMENTAL
Intervention: KW-1062 (both doses)
Number of subjects: 155
Study 30898609 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study 30898609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 29184389 — intervention group
Group type: EXPERIMENTAL
Intervention: ETV from Dong‐A ST (Baracle®)
Number of subjects: 118
Study 29184389 — intervention group
Group type: COMPARATOR
Intervention: ETV from BMS (Baraclude®)
Number of subjects: 118
Study 25488053 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 4
Study 24592747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich fraction (TRF) of palm oil, 100 mg daily from early second trimester until delivery
Number of subjects: 299
Study 24592747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 24592747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich fraction (TRF) of palm oil
Number of subjects: 299
Study 22847319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin cream products (three concentrations)
Number of subjects: 0
Study 22847319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin gel products (two concentrations)
Number of subjects: 0
Study 22847319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin (same concentration) in different vehicles (gel vs. cream)
Number of subjects: 0
Study 22847319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin and adapalene (same concentration)
Number of subjects: 0
Study 19279367 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyritinol
Number of subjects: 108
Study 19279367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 17122430 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase
Number of subjects: 6
Study 17122430 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 6
Study 14962945 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial doses of doxycycline (SDD) 20 mg twice daily
Number of subjects: 50
Study 14962945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 12166350 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg midazolam intramuscularly
Number of subjects: 22
Study 12166350 — intervention group
Group type: COMPARATOR
Intervention: No pre‐medication
Number of subjects: 22
Study 9856369 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg sustained-release indapamide
Number of subjects: 690
Study 7596722 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin for days 1 through 10, then amoxicillin for days 11 through 20
Number of subjects: 267
Study 7596722 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin for days 1 through 10, then amoxicillin-clavulanate for days 11 through 20
Number of subjects: 267
Study 7596722 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin for days 1 through 10, then placebo for either amoxicillin or amoxicillin-clavulanate for days 11 through 20
Number of subjects: 267
Study 7596722 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 267
Study 7596722 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 267
Study 7596722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 2229526 — intervention group
Group type: EXPERIMENTAL
Intervention: terbinafine 1% cream
Number of subjects: 30
Study 2229526 — intervention group
Group type: COMPARATOR
Intervention: placebo (cream vehicle)
Number of subjects: 30
Study 873028 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg amitriptyline once daily
Number of subjects: 0
Study 873028 — intervention group
Group type: COMPARATOR
Intervention: 30 mg nortriptyline with 1-5 mg fluphenazine once daily
Number of subjects: 0
Study 30153811 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) 1000‐1500mg iron
Number of subjects: 90
Study 30153811 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (FS) 200mg iron/day
Number of subjects: 90
Study 30153811 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 90
Study 30153811 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (FS)
Number of subjects: 90
Study 27501836 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial Opening Wedge HTO (OWHTO)
Number of subjects: 60
Study 27501836 — intervention group
Group type: COMPARATOR
Intervention: Lateral Closing Wedge HTO (CWHTO)
Number of subjects: 60
Study 24641777 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 240
Study 24641777 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Psychosexual
Number of subjects: 240
Study 24641777 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 240
Study 22544917 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 8
Study 22544917 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study 20168213 — intervention group
Group type: COMPARATOR
Intervention: Nicotine inhalers (NI)
Number of subjects: 22
Study 20168213 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalers (PI)
Number of subjects: 22
Study 20168213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-containing tobacco (NT)
Number of subjects: 22
Study 20168213 — intervention group
Group type: EXPERIMENTAL
Intervention: Denicotinized tobacco (DT)
Number of subjects: 22
Study 17396617 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 18
Study 17396617 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trapidil (200 mg)
Number of subjects: 18
Study 17396617 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral isosorbide dinitrate (20 mg)
Number of subjects: 18
Study 17396617 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous trapidil (100 mg)
Number of subjects: 18
Study 15590711 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (additional objective of increasing MVPA)
Number of subjects: 21
Study 15590711 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional objective)
Number of subjects: 21
Study 12085418 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR/Trandolapril 180/2 mg/day (VT)
Number of subjects: 77
Study 12085418 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide 20/12.5 mg/day (LH)
Number of subjects: 77
Study 12085418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 77
Study 9593032 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) at high dose
Number of subjects: 0
Study 9593032 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) at low dose
Number of subjects: 0
Study 9593032 — intervention group
Group type: COMPARATOR
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) administered by drops
Number of subjects: 0
Study 9593032 — intervention group
Group type: COMPARATOR
Intervention: Trivalent cold-adapted influenza vaccine (CAIV-T) administered by spray
Number of subjects: 0
Study 7551834 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Number of subjects: 558
Study 7551834 — intervention group
Group type: COMPARATOR
Intervention: Control (ECOG chemotherapy protocols)
Number of subjects: 558
Study 7551834 — intervention group
Group type: COMPARATOR
Intervention: Control (medroxyprogesterone acetate)
Number of subjects: 558
Study 2230272 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination (polymyxin, gentamicin, and nystatin as oral paste and solution)
Number of subjects: 107
Study 2230272 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination
Number of subjects: 107
Study 2230272 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate
Number of subjects: 107
Study 710319 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (4 microgram/kg . min)
Number of subjects: 10
Study 710319 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (7.5 microgram/kg . min)
Number of subjects: 10
Study 31959235 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended CBT (MS Fit)
Number of subjects: 166
Study 31959235 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face CBT
Number of subjects: 166
Study 31959235 — intervention group
Group type: EXPERIMENTAL
Intervention: MS Stay Fit (two booster sessions at 2 and 4 months after end of treatment)
Number of subjects: 166
Study 31959235 — intervention group
Group type: COMPARATOR
Intervention: No booster sessions
Number of subjects: 166
Study 30076458 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 28
Study 28556449 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 mg beloranib
Number of subjects: 107
Study 28556449 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 mg beloranib
Number of subjects: 107
Study 28556449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 25906563 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding at cervical Jiaji (EX-B 2) points combined with electroacupuncture (EA) at acupoints near ears
Number of subjects: 63
Study 25906563 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at regular acupoints near ears alone
Number of subjects: 63
Study 23108415 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg/h)
Number of subjects: 0
Study 23108415 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0
Study 21881533 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun-dried raisins (SDRs)
Number of subjects: 10
Study 21881533 — intervention group
Group type: COMPARATOR
Intervention: Sports Jelly Beans (SJBs)
Number of subjects: 10
Study 19020851 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 27
Study 19020851 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent-protected angioplasty (CAS)
Number of subjects: 27
Study 19020851 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study 17195608 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis
Number of subjects: 0
Study 17195608 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 0
Study 17195608 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 0
Study 17195608 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional management (medical treatment, early coronarography, revascularization)
Number of subjects: 0
Study 14624703 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (60 mg/day)
Number of subjects: 40
Study 14624703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10856317 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with LAM
Number of subjects: 15
Study 9104901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 90
Study 9104901 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 7523739 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (50 mg/m²) + Misoprostol (800 mcg)
Number of subjects: 63
Study 7523739 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol (800 mcg) alone
Number of subjects: 63
Study 3366415 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg dose of trans-anethole
Number of subjects: 0
Study 3366415 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg dose of trans-anethole
Number of subjects: 0
Study 3366415 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg dose of trans-anethole
Number of subjects: 0
Study 30104494 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater vegetable diversity (per increase in one different vegetable/day)
Number of subjects: 1429
Study 30104494 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher vegetable diversity in women with low vegetable intake (<2.2 servings/day)
Number of subjects: 1429
Study 25286691 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (500 mg, 1,000 mg, 2,000 mg)
Number of subjects: 60
Study 25286691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25286691 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (500 mg)
Number of subjects: 60
Study 25286691 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (1,000 mg)
Number of subjects: 60
Study 25286691 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable cefetamet sodium (2,000 mg)
Number of subjects: 60
Study 22247421 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized noninteractive website
Number of subjects: 0
Study 22247421 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized interactive website
Number of subjects: 0
Study 22247421 — intervention group
Group type: COMPARATOR
Intervention: Control website (nonindividualized risk information)
Number of subjects: 0
Study 19298635 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 200 μg once daily in the morning
Number of subjects: 52
Study 19298635 — intervention group
Group type: COMPARATOR
Intervention: Montelukast 5 mg once daily
Number of subjects: 52